Simplex Trading’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171K Sell
3,600
-1,800
-33% -$80.7K ﹤0.01% 4479
2025
Q4
$171K Sell
5,400
-8,900
-62% -$278K ﹤0.01% 4386
2025
Q3
$402K Buy
14,300
+12,300
+615% +$373K ﹤0.01% 4105
2025
Q2
$73K Sell
2,000
-1,000
-33% -$34.5K ﹤0.01% 5543
2025
Q1
$117K Sell
3,000
-2,300
-43% -$104K ﹤0.01% 4903
2024
Q4
$246K Buy
5,300
+600
+13% +$27.1K ﹤0.01% 4295
2024
Q3
$212K Buy
4,700
+2,100
+81% +$99.9K ﹤0.01% 4468
2024
Q2
$128K Sell
2,600
-3,100
-54% -$126K ﹤0.01% 5120
2024
Q1
$195K Sell
5,700
-32,800
-85% -$1.18M ﹤0.01% 4891
2023
Q4
$1.42M Buy
38,500
+26,000
+208% +$601K ﹤0.01% 2665
2023
Q3
$253K Buy
12,500
+1,400
+13% +$30.8K ﹤0.01% 4113
2023
Q2
$227K Sell
11,100
-21,600
-66% -$324K ﹤0.01% 4164
2023
Q1
$493K Buy
32,700
+22,100
+208% +$488K ﹤0.01% 3280
2022
Q4
$252K Buy
10,600
+7,400
+231% +$215K ﹤0.01% 3939
2022
Q3
$112K Buy
3,200
+900
+39% +$38.2K ﹤0.01% 5366
2022
Q2
$80K Sell
2,300
-4,000
-63% -$142K ﹤0.01% 5874
2022
Q1
$311K Buy
6,300
+3,800
+152% +$211K ﹤0.01% 4503
2021
Q4
$193K Buy
2,500
+800
+47% +$82.1K ﹤0.01% 5252
2021
Q3
$223K Buy
1,700
+100
+6% +$11.4K ﹤0.01% 5427
2021
Q2
$213K Buy
1,600
+1,570
+5,233% +$183K ﹤0.01% 5579
2021
Q1
$371K Buy
30
+21
+233% +$3.19K ﹤0.01% 3828
2020
Q4
$127K Buy
9
+7
+350% +$777 ﹤0.01% 5185
2020
Q3
$15K Buy
+2
New +$125 ﹤0.01% 6575
2020
Q2
Sell
-3
Closed -$9K 8384
2020
Q1
$9K Buy
+3
New +$81 ﹤0.01% 6552

Other funds holding TWST

Simplex Trading's TWST Position: Q1 2026 in Review

Simplex Trading reduced its Twist Bioscience (TWST) stake by 32% in Q1 2026, selling an estimated $10.1K and leaving 473 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6682.

Simplex Trading first reported a position in TWST in Q3 2020 and has held it in 12 quarters since. The position peaked at $382K in Q4 2022. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Simplex Trading held 473 shares of Twist Bioscience worth $22.5K as of Q1 2026.
  • Simplex Trading sold 225 Twist Bioscience shares in Q1 2026, an estimated $10.1K.
  • Twist Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6682 holding.
  • Simplex Trading first reported a position in Twist Bioscience in Q3 2020 and has held it in 12 quarters since.
  • Simplex Trading's Twist Bioscience position peaked at $382K in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.